We are delighted to announce that the 6th International Conference on Risk Assessment of Pharmaceuticals in the Environment (ICRAPHE), being held in Aveiro, Portugal, from October 20 – 21 2025, will this year feature a special conference session entitled ‘Risk Assessment for Impact Reduction across the Pharmaceuticals Life Cycle’ dedicated to results emerging from the ETERNAL project.

This newsletter, the sixth since the ETERNAL project started, provides ample opportunities to dig deeper into both the project’s research illuminating the environmental risks surrounding pharmaceutical manufacture and positive responses from the industry to minimize the risks through technological innovation and standardization for less impactful, more efficient, sustainable and safe by design processes.

We are delighted to announce that the 6th International Conference on Risk Assessment of Pharmaceuticals in the Environment (ICRAPHE), being held in Aveiro, Portugal, from October 20 – 21 2025, will this year feature a special conference session entitled ‘Risk Assessment for Impact Reduction across the Pharmaceuticals Life Cycle’ dedicated to results emerging from the ETERNAL project.